世界の糖尿病治療・ドラッグデリバリー市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)

GlobalInfoResearchが発行した調査報告書(GIR21JY00001)
◆英語タイトル:Global Diabetes Therapy and Drug Delivery Market 2021 by Company, Regions, Type and Application, Forecast to 2026
◆商品コード:GIR21JY00001
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2021年7月
◆ページ数:106
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2~3日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥469,800見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥704,700見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥939,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

GlobalInfoResearch社の本調査レポートでは、糖尿病治療・ドラッグデリバリーの世界市場を広く調査・分析し、今後の市場展望をまとめております。糖尿病治療・ドラッグデリバリーの種類別市場規模(吸入可能インスリン、経口インスリン、インスリンパッチ、CGMシステム、人工膵臓)、用途別市場規模(診断/クリニック、ICU、在宅ケア)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):Abbott Laboratories、Medtronic、Sanofi、Novo Nordisk、MannKind、Enteris BioPharma、Dexcom、Senseonics Holding、Medtech、Johnson & Johnson、Synertech、Zosano Pharma、Relmada Therapeutics、Eli Lilly、Transdermal Specialties
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:吸入可能インスリン、経口インスリン、インスリンパッチ、CGMシステム、人工膵臓
・用途別分析2016年-2026年:診断/クリニック、ICU、在宅ケア
・糖尿病治療・ドラッグデリバリーの北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・糖尿病治療・ドラッグデリバリーのヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・糖尿病治療・ドラッグデリバリーのアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・糖尿病治療・ドラッグデリバリーの南米市場規模2016年-2026年:ブラジル、アルゼンチン
・糖尿病治療・ドラッグデリバリーの中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
【レポートの概要】

The Diabetes Therapy and Drug Delivery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Diabetes Therapy and Drug Delivery size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Diabetes Therapy and Drug Delivery market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Diabetes Therapy and Drug Delivery market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Inhalable Insulin
Oral Insulin
Insulin Patches
CGM Systems
Artificial Pancreas

Market segment by Application, can be divided into
Diagnostic/Clinics
ICUs
Home Healthcare

Market segment by players, this report covers
Abbott Laboratories
Medtronic
Sanofi
Novo Nordisk
MannKind
Enteris BioPharma
Dexcom
Senseonics Holding
Medtech
Johnson & Johnson
Synertech
Zosano Pharma
Relmada Therapeutics
Eli Lilly
Transdermal Specialties

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Diabetes Therapy and Drug Delivery product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Diabetes Therapy and Drug Delivery, with revenue, gross margin and global market share of Diabetes Therapy and Drug Delivery from 2019 to 2021.
Chapter 3, the Diabetes Therapy and Drug Delivery competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Diabetes Therapy and Drug Delivery market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Diabetes Therapy and Drug Delivery research findings and conclusion, appendix and data source.

【レポートの目次】

1 Market Overview
1.1 Product Overview and Scope of Diabetes Therapy and Drug Delivery
1.2 Classification of Diabetes Therapy and Drug Delivery by Type
1.2.1 Overview: Global Diabetes Therapy and Drug Delivery Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Diabetes Therapy and Drug Delivery Revenue Market Share by Type in 2020
1.2.3 Inhalable Insulin
1.2.4 Oral Insulin
1.2.5 Insulin Patches
1.2.6 CGM Systems
1.2.7 Artificial Pancreas
1.3 Global Diabetes Therapy and Drug Delivery Market by Application
1.3.1 Overview: Global Diabetes Therapy and Drug Delivery Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Diagnostic/Clinics
1.3.3 ICUs
1.3.4 Home Healthcare
1.4 Global Diabetes Therapy and Drug Delivery Market Size & Forecast
1.5 Global Diabetes Therapy and Drug Delivery Market Size and Forecast by Region
1.5.1 Global Diabetes Therapy and Drug Delivery Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Diabetes Therapy and Drug Delivery Market Size by Region, (2016-2021)
1.5.3 North America Diabetes Therapy and Drug Delivery Market Size and Prospect (2016-2026)
1.5.4 Europe Diabetes Therapy and Drug Delivery Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Diabetes Therapy and Drug Delivery Market Size and Prospect (2016-2026)
1.5.6 South America Diabetes Therapy and Drug Delivery Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Diabetes Therapy and Drug Delivery Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Diabetes Therapy and Drug Delivery Market Drivers
1.6.2 Diabetes Therapy and Drug Delivery Market Restraints
1.6.3 Diabetes Therapy and Drug Delivery Trends Analysis
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Diabetes Therapy and Drug Delivery Product and Solutions
2.1.4 Abbott Laboratories Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 Medtronic
2.2.1 Medtronic Details
2.2.2 Medtronic Major Business
2.2.3 Medtronic Diabetes Therapy and Drug Delivery Product and Solutions
2.2.4 Medtronic Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Medtronic Recent Developments and Future Plans
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Diabetes Therapy and Drug Delivery Product and Solutions
2.3.4 Sanofi Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Sanofi Recent Developments and Future Plans
2.4 Novo Nordisk
2.4.1 Novo Nordisk Details
2.4.2 Novo Nordisk Major Business
2.4.3 Novo Nordisk Diabetes Therapy and Drug Delivery Product and Solutions
2.4.4 Novo Nordisk Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Novo Nordisk Recent Developments and Future Plans
2.5 MannKind
2.5.1 MannKind Details
2.5.2 MannKind Major Business
2.5.3 MannKind Diabetes Therapy and Drug Delivery Product and Solutions
2.5.4 MannKind Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 MannKind Recent Developments and Future Plans
2.6 Enteris BioPharma
2.6.1 Enteris BioPharma Details
2.6.2 Enteris BioPharma Major Business
2.6.3 Enteris BioPharma Diabetes Therapy and Drug Delivery Product and Solutions
2.6.4 Enteris BioPharma Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Enteris BioPharma Recent Developments and Future Plans
2.7 Dexcom
2.7.1 Dexcom Details
2.7.2 Dexcom Major Business
2.7.3 Dexcom Diabetes Therapy and Drug Delivery Product and Solutions
2.7.4 Dexcom Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Dexcom Recent Developments and Future Plans
2.8 Senseonics Holding
2.8.1 Senseonics Holding Details
2.8.2 Senseonics Holding Major Business
2.8.3 Senseonics Holding Diabetes Therapy and Drug Delivery Product and Solutions
2.8.4 Senseonics Holding Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Senseonics Holding Recent Developments and Future Plans
2.9 Medtech
2.9.1 Medtech Details
2.9.2 Medtech Major Business
2.9.3 Medtech Diabetes Therapy and Drug Delivery Product and Solutions
2.9.4 Medtech Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Medtech Recent Developments and Future Plans
2.10 Johnson & Johnson
2.10.1 Johnson & Johnson Details
2.10.2 Johnson & Johnson Major Business
2.10.3 Johnson & Johnson Diabetes Therapy and Drug Delivery Product and Solutions
2.10.4 Johnson & Johnson Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Johnson & Johnson Recent Developments and Future Plans
2.11 Synertech
2.11.1 Synertech Details
2.11.2 Synertech Major Business
2.11.3 Synertech Diabetes Therapy and Drug Delivery Product and Solutions
2.11.4 Synertech Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Synertech Recent Developments and Future Plans
2.12 Zosano Pharma
2.12.1 Zosano Pharma Details
2.12.2 Zosano Pharma Major Business
2.12.3 Zosano Pharma Diabetes Therapy and Drug Delivery Product and Solutions
2.12.4 Zosano Pharma Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Zosano Pharma Recent Developments and Future Plans
2.13 Relmada Therapeutics
2.13.1 Relmada Therapeutics Details
2.13.2 Relmada Therapeutics Major Business
2.13.3 Relmada Therapeutics Diabetes Therapy and Drug Delivery Product and Solutions
2.13.4 Relmada Therapeutics Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Relmada Therapeutics Recent Developments and Future Plans
2.14 Eli Lilly
2.14.1 Eli Lilly Details
2.14.2 Eli Lilly Major Business
2.14.3 Eli Lilly Diabetes Therapy and Drug Delivery Product and Solutions
2.14.4 Eli Lilly Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Eli Lilly Recent Developments and Future Plans
2.15 Transdermal Specialties
2.15.1 Transdermal Specialties Details
2.15.2 Transdermal Specialties Major Business
2.15.3 Transdermal Specialties Diabetes Therapy and Drug Delivery Product and Solutions
2.15.4 Transdermal Specialties Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Transdermal Specialties Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Diabetes Therapy and Drug Delivery Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Diabetes Therapy and Drug Delivery Players Market Share
3.2.2 Top 10 Diabetes Therapy and Drug Delivery Players Market Share
3.2.3 Market Competition Trend
3.3 Diabetes Therapy and Drug Delivery Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Diabetes Therapy and Drug Delivery Revenue and Market Share by Type (2016-2021)
4.2 Global Diabetes Therapy and Drug Delivery Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Diabetes Therapy and Drug Delivery Revenue Market Share by Application (2016-2021)
5.2 Diabetes Therapy and Drug Delivery Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Diabetes Therapy and Drug Delivery Revenue by Type (2016-2026)
6.2 North America Diabetes Therapy and Drug Delivery Revenue by Application (2016-2026)
6.3 North America Diabetes Therapy and Drug Delivery Market Size by Country
6.3.1 North America Diabetes Therapy and Drug Delivery Revenue by Country (2016-2026)
6.3.2 United States Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
6.3.3 Canada Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
6.3.4 Mexico Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Diabetes Therapy and Drug Delivery Revenue by Type (2016-2026)
7.2 Europe Diabetes Therapy and Drug Delivery Revenue by Application (2016-2026)
7.3 Europe Diabetes Therapy and Drug Delivery Market Size by Country
7.3.1 Europe Diabetes Therapy and Drug Delivery Revenue by Country (2016-2026)
7.3.2 Germany Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
7.3.3 France Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
7.3.5 Russia Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
7.3.6 Italy Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Diabetes Therapy and Drug Delivery Revenue by Type (2016-2026)
8.2 Asia-Pacific Diabetes Therapy and Drug Delivery Revenue by Application (2016-2026)
8.3 Asia-Pacific Diabetes Therapy and Drug Delivery Market Size by Region
8.3.1 Asia-Pacific Diabetes Therapy and Drug Delivery Revenue by Region (2016-2026)
8.3.2 China Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
8.3.3 Japan Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
8.3.4 South Korea Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
8.3.5 India Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
8.3.7 Australia Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Diabetes Therapy and Drug Delivery Revenue by Type (2016-2026)
9.2 South America Diabetes Therapy and Drug Delivery Revenue by Application (2016-2026)
9.3 South America Diabetes Therapy and Drug Delivery Market Size by Country
9.3.1 South America Diabetes Therapy and Drug Delivery Revenue by Country (2016-2026)
9.3.2 Brazil Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
9.3.3 Argentina Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Diabetes Therapy and Drug Delivery Revenue by Type (2016-2026)
10.2 Middle East & Africa Diabetes Therapy and Drug Delivery Revenue by Application (2016-2026)
10.3 Middle East & Africa Diabetes Therapy and Drug Delivery Market Size by Country
10.3.1 Middle East & Africa Diabetes Therapy and Drug Delivery Revenue by Country (2016-2026)
10.3.2 Turkey Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
10.3.4 UAE Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

...

【掲載企業】

Abbott Laboratories、Medtronic、Sanofi、Novo Nordisk、MannKind、Enteris BioPharma、Dexcom、Senseonics Holding、Medtech、Johnson & Johnson、Synertech、Zosano Pharma、Relmada Therapeutics、Eli Lilly、Transdermal Specialties

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の糖尿病治療・ドラッグデリバリー市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)(Global Diabetes Therapy and Drug Delivery Market 2021 by Company, Regions, Type and Application, Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。